Simon Cork
Dr. Simon Cork is a researcher at Anglia Ruskin University with expertise in obesity and metabolic health. His insights into the long-term effectiveness of weight loss medications, particularly tirzepatide, highlight the importance of understanding weight management therapies in relation to rising healthcare costs associated with obesity-related conditions.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United Kingdom | 1 | 7.00 | 0.11% | +0% | 67,886,011 | 75,095 | $2,700,000 | 2,987$ |
| Totals | 1 | 67,886,011 | 75,095 | $2,700,000 | 2,987$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United Kingdom:
Dr Simon Cork is an associate professor of physiology at Anglia Ruskin University’s School of Medicine.
7
United Kingdom:
Simon Cork highlights the unknown effects of weight-loss drugs used purely for cosmetic purposes.
5
United Kingdom:
Dr Simon Cork, a senior lecturer in physiology, commented on the preliminary results of the weight-loss pill.
6
Greece:
Simon Cork is a lecturer at Anglia Ruskin University studying obesity.
6
Guatemala:
Simon Cork is a professor at Anglia Ruskin University who has studied obesity.
7
United Kingdom:
Dr Simon Cork, of Anglia Ruskin University, noted the long-term effectiveness of tirzepatide in maintaining weight loss.
7